| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | 1 | — | — | — | — | — | 2 | — | — | 1 | — | — |
| Sell | — | 1 | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2029 | ‡‡‡‡‡ |
|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.40 |
—
—
—
|
| 2025 | 1.40 |
—
—
—
—
|
| 2024 | 1.40 |
—
—
—
—
|
| 2023 | 1.36 |
—
—
—
—
|
| 2022 | 1.29 |
—
—
—
—
|
| 2021 | 1.18 |
—
—
—
—
|
| 2020 | 0.91 |
—
—
—
—
|
| 2019 | 0.85 |
—
—
—
—
|
| 2018 | 0.85 |
—
—
—
—
|
| 2017 | 0.83 |
—
—
—
—
|
| 2016 | 0.78 |
—
—
—
—
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 93.30 | 77.70 | 68.00 | 218.00 |
| Receivables | 952.80 | 871.80 | 770.00 | 658.20 |
| Inventory | 2,212.20 | 1,981.50 | 2,048.30 | 1,905.40 |
| Other | 34.30 | 133.50 | 94.10 | — |
| 3,385.00 | 3,149.50 | 3,071.00 | 2,882.10 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 1,525.50 | 1,493.70 | 1,590.10 | 1,513.30 |
| ST’ Debt | 1,516.00 | 20.30 | 1,028.80 | 778.20 |
| Other | 16.10 | 17.50 | 2.70 | — |
| 4,440.70 | 3,241.80 | 4,317.00 | 3,188.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Aug | Nov | Feb | May | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 2,632.60 | 2,979.10 | 2,787.80 | 2,882.10 |
11,281.60
|
| ’25 | 2,794.90 | 3,195.10 | 2,841.00 | 2,781.80 |
11,612.80
|
| ’24 | 2,904.00 | 3,208.10 | 3,032.90 | 2,905.90 |
12,050.90
|
| ’23 | 2,904.30 | 3,312.90 | 3,086.50 | 2,973.30 |
12,277.00
|
| ’22 | 2,653.30 | 3,058.90 | 2,913.70 | 2,910.00 |
11,535.90
|
| ’21 | 2,678.90 | 2,995.20 | 2,771.10 | 2,739.50 |
11,184.70
|
| Aug | Nov | Feb | May | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 120.60 | 210.60 | 564.40 | 506.50 |
1,402.10
|
| ’25 | 268.60 | 485.60 | 592.00 | 345.70 |
1,691.90
|
| ’24 | 443.50 | 411.10 | 676.70 | 484.30 |
2,015.60
|
| ’23 | 263.70 | 34.10 | 405.60 | 292.00 |
995.40
|
| ’22 | 139.80 | 122.30 | 490.50 | 424.70 |
1,177.30
|
| ’21 | 284.50 | 256.90 | 528.60 | 398.10 |
1,468.10
|
| Aug | Nov | Feb | May | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | (20.00) | 170.40 | 469.20 | 398.00 |
1,017.60
|
| ’25 | 135.90 | 405.60 | 503.80 | 260.70 |
1,306.00
|
| ’24 | 300.10 | 341.00 | 581.20 | 406.00 |
1,628.30
|
| ’23 | 140.30 | (28.50) | 327.30 | 197.30 |
636.40
|
| ’22 | (13.20) | 27.70 | 391.90 | 326.70 |
733.10
|
| ’21 | 139.60 | 120.80 | 414.00 | 289.80 |
964.20
|
| Aug | Nov | Feb | May | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 0.34 | (1.39) | 0.42 | (3.37) |
(4.00)
|
| ’25 | 0.97 | 0.59 | 0.30 | 0.53 |
2.40
|
| ’24 | 0.67 | 0.60 | 0.64 | (1.18) |
0.72
|
| ’23 | (0.16) | 0.79 | 0.71 | 0.08 |
1.42
|
| ’22 | 0.49 | 0.57 | 0.45 | 0.33 |
1.84
|
| ’21 | 0.67 | 0.77 | 0.58 | 0.64 |
2.66
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.06 | 25.16 | 26.21 | 16.60 | 12.53 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.22 | 41.30 | 33.24 | 28.52 | 20.32 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18,000 | 18,600 | 18,500 | 18,300 | 17,400 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.64 | 0.66 | 0.65 | 0.63 | 0.65 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11,535.90 | 12,277.00 | 12,050.90 | 11,612.80 | 11,281.60 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.61% | 26.59% | 27.66% | 25.86% | 23.92% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,178.70 | 901.90 | 610.20 | 1,156.20 | (1,824.40) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.22% | 7.35% | 5.06% | 9.96% | (16.17%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 888.20 | 683.20 | 347.70 | 1,152.50 | (1,916.20) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 375.40 | 369.90 | 400.90 | 390.20 | 396.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.02 | 25.64 | 25.18 | 24.28 | 23.55 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 1.85 | 1.43 | 0.73 | 2.41 | (4.00) | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.45 | 2.08 | 4.21 | 3.54 | 2.93 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.92) | (0.75) | (0.81) | (0.81) | (0.80) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.53 | 1.33 | 3.40 | 2.73 | 2.12 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.45 | 18.39 | 17.78 | 18.68 | 13.27 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 480.30 | 478.90 | 478.60 | 478.30 | 479.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.88 | 24.22 | 40.93 | 9.44 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.37 | 1.36 | 1.19 | 0.94 | 0.56 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.78 | 1.90 | 1.68 | 1.22 | 0.99 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.12 | 2.05 | 1.80 | 1.56 | 1.18 | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 34.13 | 40.55 | 13.47 | 14.00 | 13.26 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,177.30 | 995.40 | 2,015.60 | 1,691.90 | 1,402.10 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (444.20) | (359.00) | (387.30) | (385.90) | (384.50) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 733.10 | 636.40 | 1,628.30 | 1,306.00 | 1,017.60 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (485.10) | (1,055.70) | (92.30) | (1,246.00) | (305.90) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,795.50 | 8,597.30 | 7,512.90 | 7,262.90 | 7,234.20 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,712.20 | 8,504.00 | 7,435.20 | 7,194.90 | 7,016.20 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,862.20 | 8,807.30 | 8,511.30 | 8,932.70 | 6,357.60 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.98% | 3.07% | 1.62% | 5.51% | (10.03%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.03% | 3.88% | 3.34% | 5.29% | (7.61%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.15% | 7.74% | 4.01% | 13.21% | (25.06%) | — | — | — |
ROE
|
Conagra Brands (CAG) is poised at a compelling inflection point in the consumer staples sector, with its iconic brands like Birds Eye and Slim Jim providing resilience amid inflation and shifting preferences. Revenue peaked at $12.28 billion in 2023 before a modest 2024 dip, but strong operational efficiency—revenue per employee at $660,054—and Pinnacle Foods acquisition synergies set the stage for stabilization, with forecasts showing a return to growth by 2028. Free cash flow per share surged 135% to $4.21 in 2024, bolstering debt reduction from $10.68 billion to $7.51 billion and supporting a ~5% dividend yield.
Profitability faced headwinds, with 2024 net income at $348 million and EPS at $0.73, but projections signal a sharp rebound—EPS tripling to $2.41 in 2025 and ROE climbing to 13.2%. Valuation metrics scream bargain: PS ratio at 1.19, PB at 1.68, and forward PE dropping to 9.4, trading at decade lows amid peers’ premiums. Insider activity shows cautious confidence, including a director’s recent purchase.
Looking ahead, innovations in sustainable packaging, plant-based products, and regenerative agriculture align with consumer trends, potentially capturing share as private labels fade and inflation cools. While short-term revenue softness and a projected 2026 loss pose risks, CAG’s fortress balance sheet and FCF strength offer asymmetric upside—20-30% potential from current levels—for patient investors.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.